How much do drug and device companies pay doctors where you live? In 2025, companies reported $2.10 billion in payments to about one million U.S. physicians, nurse practitioners and other clinicians for speaking, consulting, meals, travel and more, not counting royalties and business acquisitions. This map shows payments to doctors by state and county, by company, by drug and by type of payment.
Key findings
- $2.10 billion went to about 1 million clinicians in 2025, from more than 1,700 companies: about $6.22 per U.S. resident. Counting royalties and acquisitions, the total was $2.81 billion.
- AbbVie paid the most ($127 million to about 218,000 clinicians) and was the top paying company in 40 states. Two device makers, Medtronic and Intuitive Surgical, came next, followed by AstraZeneca and Boston Scientific.
- Meals are the most common payment by far: 14.6 million meals worth $437 million went to about 975,000 clinicians. Speaking and faculty fees ($628 million) and consulting ($603 million) are the largest by dollars and go to far fewer people.
- Washington, D.C. ($23.54 per resident), New York ($8.93) and Connecticut ($8.56) receive the most per person. Among the states, Vermont ($1.63), Wyoming, Alaska, Montana and New Mexico receive the least.
How to use the payments to doctors by state map
- Choose what to show from the menu: all payments, a type of payment, a drug group, one of the 150 companies that pay the most, or a single drug.
- Switch between dollars per resident and total dollars, and between states and counties. Click a state to see its counties.
- Hover or tap any area to see the total, the number of clinicians paid and, in the main view, the five companies that paid the most there.
- Use the Table view or Download CSV for the numbers behind any view.
Which companies pay doctors the most
| Company | Paid in 2025 | Clinicians paid |
|---|---|---|
| AbbVie | $126.7M | 217,971 |
| Medtronic | $59.7M | 75,808 |
| Intuitive Surgical | $56.3M | 15,150 |
| AstraZeneca | $51.1M | 124,318 |
| Boston Scientific | $50.5M | 75,919 |
| Lilly USA | $48.0M | 120,750 |
| Stryker | $44.1M | 48,487 |
| Janssen Biotech | $41.1M | 62,283 |
Payments tied to specific drugs
Companies also report which products a payment was related to. The drugs most often named were Dupixent (dupilumab, $42.9 million), Botox ($33.6 million), Tremfya ($30.1 million) and semaglutide (Ozempic, Rybelsus, Wegovy; $28.4 million to about 114,000 clinicians). Across the GLP-1 drug group, payments came to $47.9 million. To see where those drugs are prescribed, compare with our GLP-1 prescribing map.
Who receives the most
Nurse practitioners received the largest total ($137 million), simply because almost 194,000 of them were paid, mostly through meals. Per clinician paid, specialists receive far more: about $9,800 on average in dermatology, $7,400 in hematology and oncology, $7,300 in neurology and $6,900 in orthopedic surgery. Counties with major medical centers rank highest per resident, led by Olmsted County, Minnesota, home of the Mayo Clinic ($64.96 per resident), Manhattan and Boston’s Suffolk County. To see individual clinicians, use our list of payments by doctor, which ranks them by state, county, specialty, company, payment type or drug.
How we built this map
The payments come from CMS Open Payments (opens in a new tab), program year 2025 (published June 30, 2026). By law, drug and device makers must report payments and other things of value they give to physicians, nurse practitioners, physician assistants and certain other clinicians. We use general payments: everything except research payments and ownership interests. Each payment is placed in the county of the clinician’s practice address from the NPI registry, and rates use the U.S. Census Bureau’s American Community Survey 2020–2024 population.
- A payment is not evidence of wrongdoing. Many payments are for legitimate work, such as consulting on a device or teaching other clinicians, and clinicians can dispute records with CMS.
- The main view leaves out royalties and license fees ($487 million to about 2,400 clinicians) and acquisition payments ($220 million), because a few very large payments would dominate the map. Choose “All general payments, including royalties” to include them.
- We left out one record: a single $64.3 million speaking and faculty payment to one clinician, about 18 times the next-largest such payment in the country. It is most likely a reporting error, and it alone would have made Iowa the top state. It remains in CMS’s data.
- Payments to teaching hospitals are not included; this map covers payments to individual clinicians.
- A payment that names several drugs counts in full under each of them. Drug views include only drugs covered by Medicare Part D; vaccines and many clinic-administered drugs aren’t matched yet.
More detail is on our methodology page.
Frequently asked questions
Which state gets the most money from drug and device companies?
Per resident, Washington, D.C. ($23.54), New York ($8.93) and Connecticut ($8.56) lead, reflecting their many academic medical centers. In total dollars, the largest states receive the most: California ($250 million), Texas ($186 million), New York ($177 million) and Florida ($174 million).
How can I look up payments to my own doctor?
Search our payments by doctor list by name, or open the clinician’s profile from Find a doctor: each profile lists the companies and payment types. CMS also publishes every record on the Open Payments website (opens in a new tab).
What counts as a payment?
Anything of value over a small threshold: meals, travel, speaking and consulting fees, honoraria, education, grants, gifts, royalties and more. Each record names the company, the type of payment and, often, the products it relates to.